MOGAD is an inflammatory disorder mainly affecting the optic nerve, spinal cord, and brain. As a result of enhanced clinical testing capabilities, MOG antibodies are being detected in children with central nervous system demyelinating diseases, including pediatric-onset multiple sclerosis (POMS). In this episode, Doctor Amin Ziaei, MD, PhD, University of California – San Francisco, San Francisco, CA, discusses his research which compares the genetic basis of POMS to confirmed MOGAD cases.
